Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
April 9, 2019 Off

LEO Pharma and Elektrofi Expand Partnership to Co-Develop New Antibodies with the Aim of Achieving Improvements in Drug Delivery within Dermatology

By BusinessWire

BALLERUP, Denmark–(BUSINESS WIRE)–LEO Pharma A/S, a global leader in medical dermatology and Elektrofi, a Boston- based biotechnology company focused on…

April 9, 2019 Off

Nanna Therapeutics Awarded £829,892 Innovate UK Grant to Discover Novel Drugs Leveraging Its Nanoscale Medicines Discovery Engine

By BusinessWire

Expands Scientific Advisory Board with Appointment of Prof. David Spring CAMBRIDGE, England–(BUSINESS WIRE)–Nanna Therapeutics Ltd, a biotechnology company developing novel…

April 9, 2019 Off

Boehringer Ingelheim Launches the First-Ever Registered Stem Cell-Based Veterinary Medicine

By BusinessWire

European Commission has granted marketing authorisation for the first stem cell-based product in animal health Arti-Cell® Forte is a unique…

April 9, 2019 Off

PIXUVRI® (pixantrone) Receives Positive CHMP Opinion to Convert Conditional Approval into Standard Marketing Authorization in Patients with Aggressive non-Hodgkin B-cell Lymphoma

By BusinessWire

Pixantrone has been available to patients since 2012 following a conditional approval from the European Medicines Agency PARIS–(BUSINESS WIRE)–Servier today…

April 9, 2019 Off

Poxel and Sumitomo Dainippon Pharma Announce Positive Top-Line Results for Imeglimin Phase 3 Trial (TIMES 1) in Japan for the Treatment of Type 2 Diabetes

By BusinessWire

Imeglimin Phase 3 trial (TIMES 1) met its primary and main secondary endpoints Imeglimin Phase 3 TIMES 3 16-week, double-blind,…

April 9, 2019 Off

EMMAC Life Sciences: Acquisition of Rokshaw, a Leading UK Specials Manufacturer

By BusinessWire

Immediate access to UK medical cannabis market LONDON–(BUSINESS WIRE)–EMMAC Life Sciences Ltd (“EMMAC” or the “Company”), the European independent medical…

April 9, 2019 Off

Vifor Pharma and Akebia Therapeutics Announce Expansion of Licence Agreement

By BusinessWire

Expanded licence creates opportunity for vadadustat to be provided to up to 60% of U.S. dialysis patients, subject to FDA…

April 9, 2019 Off

Vifor Pharma and Akebia Therapeutics Announce Expansion of License Agreement

By BusinessWire

Expanded license creates opportunity for vadadustat to be provided to up to 60% of U.S. dialysis patients, subject to FDA…

April 8, 2019 Off

Teva to Host Conference Call to Discuss First Quarter 2019 Financial Results at 8 a.m. ET on May 2, 2019

By BusinessWire

JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will issue a press release on its…

Bio-Rad Receives U.S. FDA Clearance for the IH-500, Expanding Its Offering for the Blood Testing Market
April 8, 2019 Off

Bio-Rad Receives U.S. FDA Clearance for the IH-500, Expanding Its Offering for the Blood Testing Market

By BusinessWire

Bio-Rad has bagged clearance from the U.S. Food and DrugAdministration (FDA) for its IH-500, an automated randomaccess system for blood typing and screening.

Posts pagination

Previous 1 … 3,290 3,291 3,292 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine